Hologic announced that its Cynosure division is releasing the recently FDA-cleared TempSure RF platform for surgical and non-surgical aesthetic applications. The device provides 300 watts of energy at 4 MHz, allowing for precise work in creating fine incisions in delicate tissues such as eyelids, ears, and even labia!
Hologic believes its device causes less heat damage to nearby tissues compared to competitors and less noticeable scarring is left at the end. The device comes with a set of different electrodes that are dedicated to working with different tissue types on a single device.
“TempSure Surgical is truly a breakthrough technology that has improved my surgical procedures and delivered fantastic results,” said Dr. Barry DiBernardo of New Jersey Plastic Surgery, in a published statement. “I immediately noticed cleaner cuts and optimum coagulation during surgery, which gives me the confidence to tell my patients they will experience less bruising and better wound healing. With the addition of TempSure Surgical, I am now able to perform improved surgical incisions and also offer noninvasive wrinkle reduction with TempSure Envi. This technology has revolutionized my practice — and it will revolutionize your practice.”
Some related information, according to Hologic:
Cynosure also has returned TempSure™ Vitalia hand pieces and probes to the market and will continue to market its MonaLisa Touch® CO2 laser following the U.S. Food and Drug Administration (FDA) inquiry on products used in energy-based women’s health procedures. Over the past several months, Cynosure worked closely with the FDA and reviewed and updated all its marketing and promotional materials to ensure they are consistent with the FDA’s labeling expectations.